ESCO2 and hepatocellular carcinoma: Kaplan-Meier survival analyses for HCC patients were performed using TCGA data to determine the relationship between ESCO2 expression and prognosis, focusing on overall survival (OS), disease-free interval (DFI), disease-specific survival (DSS), and progression-free interval (PFI).